PARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...

Objective: The genetic markers for the detection or treatment of cervical squamous cell carcinoma (CESC) are not yet complete. This study aimed to identify the role of MSMO1 (Alternative name: SC4MOL) ...

Introduction: In this study, we explored the effectiveness and safety of the immune checkpoint inhibitor camrelizumab in combination with chemotherapy for the treatment of cervical cancer by ...

PARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...

This article is sponsored by Pacira BioSciences, Inc. While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the ...

Correspondence to Dr Sally Graglia, Emergency Medicine, San Francisco General Hospital and Trauma Center, San Francisco, CA 94110, USA; sally.graglia{at}gmail.com A right-hand dominant woman aged 46 ...